Dr. Anita Rogowicz-Frontczak | Medicine | Research Excellence Award

Published on by Computer Scientists Awards

Dr. Anita Rogowicz-Frontczak | Medicine | Research Excellence Award

Assistant Professor | Poznan University of Medical Science | Poland

Dr. Anita Rogowicz-Frontczak is a clinical researcher specializing in diabetology, endocrinology, and internal medicine, with a strong focus on diabetes, insulin resistance, thyroid disorders, and cardiovascular risk. Her research explores metabolic and autoimmune interactions, particularly in type 1 diabetes and thyroid disease, contributing to improved clinical understanding and patient care strategies. She has authored numerous peer-reviewed publications and educational contributions in metabolic health and clinical nutrition. Her scholarly impact is reflected in Scopus with 484 citations across 26 documents and an h-index of 12, alongside a strong Google Scholar presence, demonstrating sustained research influence and academic contribution.

Citation Metrics (Scopus)

500

400

300

200

100

0

Citations
484

Documents
26

h-index
12

■ Citations
■ Documents
■ h-index


View Scopus Profile View ORCID Profile

Featured Publications

Igor Samatoshenkov | Medicine | Best Researcher Award

Published on by Computer Scientists Awards

Mr. Igor Samatoshenkov | Medicine | Best Researcher Award

Vascular surgeon, Uniclinic Brandenburg, Medical school Brandenburg, Germany

Dr. Samatoshenkov Igor Valeryevich  is an accomplished cardiovascular surgeon, innovator, and medical entrepreneur, currently based in Brandenburg, Germany. With an MD and PhD in medical sciences, he has made significant strides in the fields of vascular surgery, regenerative medicine, and gene therapy. He is the founder and CEO of “Angiolife,” a Skolkovo-based biotech company pioneering gene-drug research. As a dedicated academic and clinical expert, Dr. Samatoshenkov has been actively involved in cutting-edge surgical practice, scientific research, and medical education. 🧬💉

Publication Profile

Scopus

ORCID

🎓 Education Background

Dr. Samatoshenkov earned his PhD in 2021 from Kazan Federal University 🎓. His earlier training includes a medical degree from Kazan State Medical University (2009–2015), where he also specialized as a professional medical translator (2012–2014). He pursued advanced phlebology training in endovenous laser obliteration in 2018 in Moscow. His comprehensive education has built a solid foundation for his clinical and research pursuits. 📚🩺

💼 Professional Experience

Dr. Samatoshenkov has over a decade of experience in cardiovascular surgery and medical education. Since 2017, he has been serving in the Department of Cardiosurgery No. 1 and is a graduate student in the Department of Histology, Cytology, and Embryology. From 2015 to 2017, he was an attending physician in the Department of Heart Surgery at the ICDC. He also contributed to academia as an assistant in the Department of Normal Anatomy (2016–2017) and led several student scientific circles from 2011 to 2014. In 2018, he founded “Angiolife,” advancing gene-based therapeutics. 🏥💡

🏆 Awards and Honors

Dr. Samatoshenkov’s innovations have been widely recognized. He won the 2023 National Competition of Innovative Ideas in Medicine by AMTEC Foundation 🏅 and the “Top 50 Innovative Ideas” contest in Tatarstan 🥇. He was a finalist in the 2022 MEDLEADS competition and ranked 2nd in the 2021 All-Russian Intellectual Property contest “Intellect.” He also received accolades from the Academy of Sciences of Tatarstan (2020) and Innopolis Startup Tour (3rd place). 🌟🔬

🔬 Research Focus

Dr. Samatoshenkov’s research spans cardiovascular regeneration, gene and stem cell therapy, and surgical innovation. His pioneering studies in VEGF, ANG, and GDNF gene delivery have opened promising avenues in post-ischemic tissue recovery. His experimental models and cell-mediated delivery techniques are pushing the boundaries of modern medicine. 🧪🧠

🔚 Conclusion

With an exceptional blend of clinical excellence, scientific ingenuity, and entrepreneurial vision, Dr. Igor Samatoshenkov is a leading figure in cardiovascular innovation and regenerative therapy. His mission continues to bridge advanced research with real-world patient solutions. 🌐

📘 Top Publications

  1. Modeling of acute venous lesion of the lower extremities in experiment (2016) – Clinical and Experimental Surgery
    Authors: I.V. Samatoshenkov, B.M. Mirolyubov
    Cited by: —
    Journal Link: Not publicly available online

  2. Effects of direct and indirect delivery of the VEGF gene by cord blood cells to the area of limb ischemia in rats (2017) – Morphological Statements
    Authors: I.V. Samatoshenkov, S.A. Andreev, N.V. Boychuk
    🔗 https://doi.org/10.20340/mv-mn.2017(25).4.14-17
    Cited by: 5+

  3. Comparison of the effectiveness of stimulating angiogenesis in ischemic limbs… (2019) – Creative Cardiology
    Authors: I.V. Samatoshenkov et al.
    🔗 https://doi.org/10.24022/1997-3187-2019-13-3-250-262
    Cited by: 10+

  4. Stimulation of angiogenesis of rat skeletal muscle… (2020) – Morphology
    🔗 https://doi.org/10.34922/AE.2020.157.1.006
    Cited by: 15+

  5. Adenoviral vector delivery of VEGF, angiogenin, and GDNF genes promotes angiogenesis… (2020) – BioNanoScience
    Authors: I.V. Samatoshenkov et al.
    🔗 https://doi.org/10.1007/s12668-019-00688-y
    Cited by: 25+

  6. New experimental model of hind limb ischemia in pot-bellied pigs (2023) – Microvascular Research
    Authors: Igor Samatoshenkov et al.
    🔗 https://doi.org/10.1016/j.mvr.2022.104425
    Cited by: 8+

  7. Combined delivery of the VEGF, ANG, and GDNF genes stimulates angiogenesis and post-ischemic regeneration (2024) – Current Issues in Molecular Biology
    🔗 https://doi.org/10.3390/cimb46080507
    Cited by: 12+

 

Maria Asunción Aguilar | Health Sciences | Women Researcher Award

Published on by Computer Scientists Awards

Prof Dr. Maria Asunción Aguilar | Health Sciences | Women Researcher Award

Catedrática de Universidad, Universitat de Valencia, Spain

👩‍🔬 Maria A. Aguilar (also known as Maria Asunción Aguilar) is a Full Professor at the University of Valencia in the Department of Psychobiology. With a research focus on psychopharmacology and physiological psychology, she has made significant contributions to understanding the brain mechanisms underlying addiction and stress resilience. Since November 2017, she has held the prestigious position of Catedrático at the University of Valencia.

Publication Profile

ORCID

Strengths for the Award:

  1. Extensive Research in Psychobiology: María A. Aguilar is a full professor of Psychobiology at the University of Valencia, focusing on neuropsychopharmacology and physiological psychology. Her work on the interaction between social stress, drug addiction, and brain function, particularly in the context of cocaine and MDMA, contributes valuable insights to women’s health and psychology, making her a strong contender.
  2. Prolific Publication Record: With 122 published works, Aguilar’s research covers cutting-edge topics such as the role of social stress in drug addiction and the therapeutic effects of substances like cannabidiol. These areas have significant implications for mental health treatments, relevant to women’s health challenges.
  3. Leadership and Experience: She has held prominent academic roles, including being a full professor since 2017 and previously a tenured professor since 2002. Her leadership in academic settings and sustained research output strengthens her profile for the award.
  4. Innovative Contributions to Neuroscience: Aguilar’s studies on glutamatergic receptors and their role in the brain’s response to social defeat and drug addiction present novel approaches to understanding mental health disorders, making her a thought leader in neuroscience.

Areas for Improvement:

  1. Specific Focus on Women’s Health: Although her research addresses critical aspects of mental health, especially addiction and stress, a more direct focus on gender-specific issues in psychopharmacology, such as how these conditions uniquely impact women, could make her case stronger for an award dedicated to women’s research.
  2. Outreach and Public Engagement: While her academic contributions are significant, further involvement in public health initiatives or policy impact related to women’s mental health might enhance her candidacy. Increasing visibility in terms of applying her research to real-world settings could further strengthen her application.

Education

🎓 Maria A. Aguilar completed her specialization in Psychopharmacology and Physiological Psychology, with a focus on understanding the neural circuits involved in addiction and behavior. Her doctoral thesis was supervised by renowned experts Jose Miñarro and Vicente Simón.

Experience

💼 Maria A. Aguilar has had a distinguished academic career, starting as a Professor Titular at the University of Valencia in 2002 and later being promoted to Full Professor in 2017. Her teaching and research primarily focus on psychobiology, particularly studying addiction, drug abuse, and neuroplasticity.

Research Focus

🔬 Her research explores the neurobiological mechanisms of addiction and stress, especially focusing on drug-seeking behavior, neuroplasticity, and the role of glutamatergic receptors. She has conducted extensive studies on the effects of cocaine, MDMA, and cannabidiol on the brain’s reward systems.

Awards and Honors

🏅 Professor Aguilar has received various accolades throughout her career, including recognition for her groundbreaking research in psychopharmacology and neurobiology. She is a member of several professional organizations and continues to contribute to advancing the understanding of brain mechanisms in behavior.

Publication Top Notes

📝 Top Publications:

Inhibition of Nitric Oxide Synthesis Prevents the Effects of Intermittent Social Defeat on Cocaine-Induced Conditioned Place Preference in Male Mice (2024). Published in Pharmaceuticals DOI: 10.3390/ph17091203. Cited by: 6 articles.

Intermittent voluntary wheel running promotes resilience to the negative consequences of repeated social defeat in mice (2022). Published in Physiology & Behavior DOI: 10.1016/j.physbeh.2022.113916. Cited by: 12 articles.

Cannabidiol prevents priming- and stress-induced reinstatement of the conditioned place preference induced by cocaine in mice (2021). Published in Journal of Psychopharmacology DOI: 10.1177/0269881120965952. Cited by: 20 articles.

Role of NMDA and AMPA glutamatergic receptors in the effects of social defeat on the rewarding properties of MDMA in mice (2019). Published in European Journal of Neuroscience DOI: 10.1111/ejn.14190. Cited by: 15 articles.

Conclusion:

María A. Aguilar is a highly suitable candidate for the Research for Women Award due to her extensive contributions to psychobiology, particularly in the study of drug addiction and stress-related behaviors. Her long academic career, leadership roles, and prolific publication record highlight her dedication to advancing research in neuroscience. To increase her chances of winning, focusing more on the gender-specific implications of her work and enhancing public outreach could further align her profile with the award’s goals.

Juan Valdivieso | Health Sciences | Best Researcher Award

Published on by Computer Scientists Awards

Mr. Juan Valdivieso | Health Sciences | Best Researcher Award

Research Lead, Savana, Spain

Dr. Juan Valdivieso is a distinguished medical professional specializing in immunology and oncology. He completed his medical degree in Ecuador and furthered his education in Spain, where he gained expertise in immuno-oncology. With extensive experience in both clinical practice and research, Dr. Valdivieso is currently a Medical Research Lead at SavanaResearch, Madrid. His work, particularly in the areas of rheumatoid arthritis and CAR-T cell monitoring, has been published in renowned scientific journals.

Publication Profile

Scopus

Strengths for the Award:

  1. Extensive Research Background: Dr. Juan Luis Valdivieso Shephard has a strong research background, with several publications in prestigious journals like Rheumatology (Oxford) and Heliyon. His work covers critical areas such as immunology, oncology, and artificial intelligence in medical research.
  2. Diverse Clinical Experience: He has gained significant clinical experience through his residency in immunology, rotations in oncology, and work as a medical researcher. This practical experience complements his research, making his contributions valuable in both clinical and research settings.
  3. Active in Scientific Community: Dr. Valdivieso Shephard has actively participated in various national and international conferences, presenting his research findings. His involvement in these events highlights his commitment to advancing his field and sharing knowledge with the broader scientific community.
  4. Collaborative Researcher: He has collaborated with various experts, contributing to multi-author publications and book chapters. This ability to work in a team and contribute to significant scientific literature is a strong point in his favor.
  5. Language Proficiency: Proficiency in both Spanish and English enables him to engage with a broader audience, increasing the impact of his research internationally.

Areas for Improvement:

  1. Further Specialization: While Dr. Valdivieso Shephard has a broad research portfolio, focusing more deeply on a specific niche within immunology or oncology could enhance his expertise and make him a leading figure in that area.
  2. Leadership Roles: Taking on more leadership roles in research projects or professional organizations could strengthen his profile. Mentoring junior researchers and leading large-scale studies would further demonstrate his capabilities.
  3. Grant Acquisition: Securing more research grants and funding would not only boost his research endeavors but also underscore his ability to attract resources, a key criterion for many research awards.

Education 🎓

Dr. Valdivieso earned his medical degree from the University of Cuenca, Ecuador, in 2013. He later obtained the Spanish equivalency of his medical degree in 2016. He completed a residency in immunology at Hospital Universitario La Paz in Madrid, Spain, from 2017 to 2021, followed by a master’s degree in Immuno-Oncology from Universidad Rey Juan Carlos, which he completed in 2023.

Experience 🏥

Dr. Valdivieso’s career began in Ecuador, where he served as a rural physician and later as an Onco-hematology doctor at Hospital José Carrasco Arteaga. Since 2021, he has been the Medical Research Lead at SavanaResearch in Madrid, Spain. His professional background also includes occasional teaching roles at MIR MediPlus.

Research Focus 🔬

Dr. Valdivieso’s research primarily focuses on immunology, oncology, and the application of artificial intelligence in medical research. His notable projects include studying anti-TNF treatment responses in rheumatoid arthritis and standardizing CAR-T cell monitoring techniques.

Awards and Honors 🏅

Throughout his career, Dr. Valdivieso has received recognition for his contributions to medical research, particularly in the field of immunology. His work has been cited in numerous scientific publications, reflecting the impact of his research on the medical community.

Publication Top Notes 📚

“Colitis expands the phenotype of PAAND patients: new case report and review of the literature” – Rheumatology (Oxford), 2021
Cited by 5 articles

“Hypomorphic variant in TRNT1 induces a milder autoinflammatory disease with congenital cataracts and impaired sexual development” – Rheumatology, 2021
Cited by 7 articles

“Variants in CASP10, a diagnostic challenge: Single center experience and review of the literature” – Clinical Immunology, 2021
Cited by 4 articles

“Predicting anti-TNF treatment response in rheumatoid arthritis: An artificial intelligence-driven model using cytokine profile and routine clinical practice parameters” – Heliyon, 2024
Cited by 3 articles

“The challenge of standardizing CAR-T cell monitoring: A comparison of two flow-cytometry methods and correlation with qPCR technique” – Cytometry Part A, 2024
Cited by 2 articles

Conclusion:

Dr. Juan Luis Valdivieso Shephard is a strong candidate for the Best Researcher Award, given his extensive research experience, active participation in the scientific community, and contributions to immunology and oncology. His strengths, particularly in research and collaboration, make him a worthy contender. However, focusing on further specialization and leadership in research could enhance his candidacy for future awards.